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Dichloroacetate Enhances Myocardial Functional and Metaholic Recovery 
Following Global Ischemia 
Joyce A. Wahr, MD, Keith F. Childs, and Steven F. Bolling, MD 
This study was undertaken to determine the effect of dichlo- 
roacetate (DCA) on myocardial functional and metabolic 
recovery following global ischemia. Sixteen isolated rabbit 
hearts were subjected to 120 minutes of mildly hypothermie 
(34°C) cardioplegic arrest with multi-dose, modified St. 
Thomas’cardioplegia. Following ischemia, hearts were reper- 
fused with either a physiologic salt solution (PSS) as con- 
trols, (CON, N = 10). or PSS containing DCA (DCA, N = 6) at 
a concentration of 1 mmol/L. Functional and metabolic 
indices were determined at baseline and at 15, 30, and 45 
minutes of reperfusion. Results were analyzed using analysis 
of variante (ANOVA, Sheffe F test) and significante was 
defined as P < 0.05. Functional recovery was significantly 
better in hearts reperfused with DCA. Developed pressure 
(DP) recovered to 62 2 4% of baseline in DCA hearts, 
compared to 37 f 8% in CON hearts. Recovery of dP/dt was 
also improved in DCA versus CON hearts (67 + 5 ~43 + 10%). 
Coronary blood flow was not different between groups 
G LOBAL MYOCARDIAI. ischcmia may rcsult in poer functional recovery despite rcstoration of myocardial 
hlood flow and rcpletion of substrate neccssary for cncrgy 
production. Hypothcrmic cardioplcgic arrest is frequcntly 
used to providc myocardial protection during the pcriod ol 
mandatory myocardial ischcmia that occurs during cardiac 
surgcry. Even with thcsc tcchniques. myocardial mctabolic 
requiremcnts arc nat eliminated. and functional and meta- 
bolic recovery is often impaircd at rcpcrfusion. Depletion 
of ATP levcls and/or slow restoration of ATP Icvcl~ 
following ischemia appcx to bc critical factors in this poor 
functional recovery. and agents that cnhancc rcpletion 01 
ATP following ischemia should improvc rccovcry. Oxida- 
tivc phosphorylation is a critical sourcc of cellular ATP; :I 
kcy step in this mctabolic pathway is thc oxidation of 
pyruvatc to acetyl CoA by thc multi-enzymc complex 
pyruvatc dehydrogcnasc (PDH). Dichloroacctatc (DC’A) 
has been shown to enhance the activity of PDH in virtually 
all tissues.’ and has been previously notcd to limit thc ST 
segment clevation associatcd with abrupt coronary occlu- 
sion in dogs.? DCA has also been shown to cnhance glucose 
oxidation in isolated, cndotoxin-shocked rat hcarts,’ and 10 
improvc cardiac index in paticnts with scvcrc lectic acido- 
sis.4,’ DCA has heen uscd in humans with littlc or no signs 
oftoxicity.’ 4.5 and thus ha> potential for use in patients with 
myocardial ischcmia, cspccially thc induccd ischcmia that 
occurs during cardiac surgery. 
It was postulatcd that IXIA. by incrcasing thc activiry of 
PDH, could enhancc the functional and metabolic myocar- 
dial recovery following global ischcmia during cold car- 
dioplegic arrest in isolatcd. perfuscd rahbit hcarts. 
either at baseline or during reperfusion, but myocardial 
oxygen consumption (MQOz) was increased in the DCA 
versus CON hearts (71 2 10% of baseline, Y 51 2 lg%). 
Diastolic compliance during reperfusion was improved in 
those hearts receiving DCA, as was myocardial mechanica1 
use efficiency (DP/MVO,). Correction of myocardial tissue 
pH to baseline values was similar in both groups, indicating 
that the beneficial effect on functional recovery seen with 
DCA was not solely related to amelioration of acidosis. The 
enhanced myocardial function and improved metabolic sta- 
tus noted with DCA may result from increased oxidative 
phosphorylation due to altered pyruvate dehydrogenase 
(PDH) activity. 
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MATERIAL AND METHODS 
Studies wcrc pcrformed in 16 isolated. pcrfused rahbit hearts. 
Male New Zealand rahhits weighing 3 to 4 kg were anesthetized 
with intravcnously administered sodium pentobarbital (10 mgikg). 
after which the heart was removcd through a median sternotomy. 
The heart was rapidly excised and immersed in ice-cold physiologic 
salt solution (PSS) containing 11X.0 mmol/L NaCII. 4.0 mmol!L 
KCI, 22.3 mmol:L NaHCO?. ll.1 mmol!L glucose, 0.66 mmolíl. 
K-HPO.,. 1.23 mmol!L MgCIz, and 2.38 mmol;L C~CIJ and was 
suspended from a perfusion column by aortic cannulation within 30 
seconds of excision (Langendorffpreparation). Coronary perfusion 
was estahlishcd at X0 mmllg with PSS equilihrated with 95% 
0:.5% CO,. The oxygen tension of thc perfusate was maintained 
betwccn 4%) and SSO mmHg, and thc perfusate temperature was 
kept at 37°C‘ by means of a heat exchangcr in the perfusion column 
(Fig 1). 
Aftcr coronay pcrfusion WHS initiated. the heart generally 
regained sinus rhythm. hut in the presence of persistent fibrillation, 
immediate direct-current cardioversion was carried out. Whilc the 
heart was perfused on thc column. a portion of the mitral valve with 
its chordae was exciscd, and a latex balloon, connccted to tubing 
filled with saline solution. was introduced into the left ventricle 
through thc mitral orifice (Fig 2). l‘hc halloon was sewn in place in 
such a way as to allow passive vrnting of thc lelt ventricular (LI’) 
cavity. The halloon was connected to a Statham P?.JDb (Gould. 
Akron. 011) prcssurr transduccr for continuous measurement of 
lelt ventricular pressure (LVP) and thc first derivativr of LVP 
(dP/dt). which were recorded on an IBM (Purchase. NY) analog to 
digital system. Th< supcrior vena cava ;md infcrior vena cava were 
ligatcd. I‘he pulmonary artcry was cannulated to enable timed 
collcction mcasurcment\ of coronary flow and thc cannula was 
connectcd I<> a C‘lark electrode (C’hcmical microsensor. Diumond 
Elcctro-Tech. Inc. Ann Arbor. Ml) for continuous measurement of 
the partial prrssure of oxygen in the coronary elflucnl. C‘oronav 
Row was measurcd hy performing timed collections of thc pulmo- 
nary effluent flow with ;1 graduated cylinder. A Khuri Regional 
Tissue pil Monitor (Vascular Tcchnology. (‘helmsford. MA) was 
placcd in thc mid-left ventricular myocardium for continuous 
rccordingof myoardial temperaturc and pH. 
Dcvcloped pressure (DP) was delined as pcak systolic pressurc 
(PSP) minus end-diastolic pressure (EDP). The product of hcart 
ratc (HR) and DP (PRP. mmHg/min) was calculated to provide an 
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Fig 1. Perfurion column for isolated heart prepsration. (Reprinted 
with permission.*) 
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estimate of changes in myocardial work. Myocardial oxygen con- 
sumption (MYO?) was calculated as Mq02 = CF X [(PaO>-PvO2) 
x (c;7óo)], where CF is coronary flow (mL/minlg). (PaOz-PvOz) 
is the differente in the partial pressure of oxygen (POz, mmHg) 
hetween perfusate and coronary effluent Row, and c is the Bunsen 
solubility coefficient of 0~ in perfusate at 37°C (22.7 FL Oz/ 
aim/mL perfusate). 
After completing instrumentation and performing calibrations, 
left ventricular halloon volumes were varied over a range of values 
to construct modified left ventricular function curves. In this 
marmer. it was possible to delìne a specific balloon volume 
(end-diastolic volume. [EDV]) that was associated with a devel- 
oped pressure between 100 and 140 mmHg. This volume was 
maintained the same for cach heart during baseline and reperfu- 
sion conditions. The intraventricular balloon volumes were nat 
adjustcd to produce specific end-diastolic pressures (rather, a 
defìned leve1 of systolic pressure development). hut end-diastolic 
pressures at baseline greater than 10 mmHg were not considered 
acceptable. Hearts characterized by developed pressures less than 
I(H) mmHg or greater than 140 mmHg were nat used. After 
determination of the best EDV for each heart. the balloon volume 
was increased in increments. permitting estimation of diastolic 
stiffness at baseline and reperfusion by measuring the slape of 
linearized EDP versus EDV curves for each heart. 
Aftrr a JO-minute stabilization period, baseline measurements 
were made in each heart. Hearts were then rendered globally 
ischemic by interruption of the perfusion column immediately 
above the aortic cannulation site. The intraventricular balloon was 
dellated, and IS mL of cardioplegia (modified St. Thomas’s 
solution. 4°C) were administered. All hearts were maintained at 
34°C by means of a circulating water jacket during 120 minutes of 
total ischemia. All hearts received 10 mL of cardioplegic solution 
every 30 minutes during ischemia. Multidose administration of 
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Fig 2. Balloon inserted into Ieft ventrfcular cavity for recording functional measurements. Abbreviations: LV, left ventricle; PA, pulmonary 
artery. (Reprinted wtth permission.‘) 
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cardioplrgic xolution ib used commonly on Ihc clinicul arena ,lnd I\ 
consistent with fhe experimental studies reported previou+. 
When thr 2-huur ischcmic period wa rndcd. thc hcart5 &crc 
reperfused 31 X0 mmHg with oxyecnated PSS at 37X‘ and rhc water 
bath trmperalurc was incrcascd to 37°C. (‘ontrol hcarth (N = 10) 
were rcpcrfussd with the same PSS used during hasclinc. and D(‘A 
hcarth (N = 6) wcrc rcpcrfused with PSS confaining I mM DCA. A 
fresh bolution of DCA (Sigma C’hemicals. SI. Lot& MO) wa 
preparcd for each experiment. and tht: solution was adjustsd IO a 
pil of 73.5 to 7.45. Delìbrillation was pcrformcd as nceded during 
the initial 3 minutes of reperfusion. During thc first IS minuto of 
rcperfusion the intraventricular balloon was kept deHatcd IO 
simulate the brating, nonworking condition. Aftcr thc initial 15 
minutcs of rcpcrfusion. thc LV balloon was retilled to the preiscb 
cmic EDV and hcmodynamic and mctaholic mcasurcmcnh wcrc 
made. The balloon remained inHated for the remainder of the 
rcpcrfusion prriod and mrasuremrnlx were ohtained after 15. 30. 
and 45 minutcs of reperfusion. Diasfolic sfiffness (compliance) wa’r 
dctcrmincd as at hasclinc. 
After 45 minutes of rsperfusion, all hearts wcrc rcmoved from 
the perfusion apparatus. Wet wcight of rhc hart was detcrminrd 
at the conclusion of cach experiment after trimming the grcat 
vessrls and fat and blot drying. Thc myocardial water content was 
drlermined by weighing a frcsh specimen of myocardium. allowing 
this sample 10 drsiccale for 48 hours at 80°C. and then reweighing 
thc samplc. Percent water was calculatcd using thc formule 
([I - dry weight:wel weight] X 100 = % H-0). 
This protocol was approved hy thc University of Michigan 
Institutional Animal Care and Ure Committee and complied with 
thc “Principles of Laboratory Animal Care” and the “Guide for 
thc Carc and Usc of Laboratory Animals” (NIH Publication No. 
X0.23. rcviscd lY7X). 
Values reported in thc 1~x1. tables. and figurcs arc means ? 
standard deviation. Data were evahmted with rcpealed measures 
analyais of variance (ANOVA). When significant F values were 
ohtaincd, Schcffc‘s te\t was used to distinguish which time pcriods 
(>r groups diffcred from ene another signifìcantly. Diffcrences were 
con>idcred significant when I’ < 0.05. 
RESULTS 
Therc wcrc no significant diffcrences at basclinc for 
heart ratcs. DP, or dP/dt valucs bctween control hcarts and 
DCA hearts. and basclinc DP averagcd 110 mmHg for ai1 
hearts. Left ventricular systolic and diastolic functional 
mcasuremcnts of DP and dP/dt made after 45 minutes 01 
repcrfusion are shown in Table 1 as percent recovery of 
function compared to bascline values. Diastolic stiffness (or 
compliancc, AEDP!AEDV) is exprcsscd as the slopc of the 
lint that best dcscribed the change in end-diastolic prcssure 
for each 0.1 mL change in end-diastolic volume. 
After 120 minutcs of hypothermie ischemia and 45 
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Fig 3. Functional recovery at 45 minutes of reperfusion. Values are 
means + standard deviation. ??P c 0.05. C, CON; ??, DCA. 
minutes of reperfusion, control hcarts recovered 37 -t X% 
of baselinc DP and 43 ? 10% of baseline dP/dt (Fig 3). 
Hearts reperfused with DCA showcd significantly better 
recovery of function, to 62 rt 4% of baselinc DP and 67 * 
5% of baselinc dP/dt (P < 0.05 versus control hearts). 
Diastolic stiffness was significantly improved in hearts 
reperfused with DCA compared to CON (Fig 4). Aftcr 45 
minutes of repcrfusion. thc control hearts were character- 
izcd by a higher diastolic stiffness slopc value of 156.7 (a 
15.6 2 0.8 mmHg risc in EDP for cach 0.1 mL incrcasc in 
EDV) versus a diastolic stiffness value of 82.6 5 I 1 in those 
hcarts reperfused with DCA (P < 0.05). 
Myocardial metabolic indices are shown in Tablc 2. 
Coronary blood flow was nat different between control 
hcarts and these reperfuscd with DCA at basclinc or at any 
time during reperfusion. Bascline valucs were 41 i Y 
mL/min and 38 ? 5 mlimin in the CON and DCA hearts. 
respectivcly. and 38 ? 12 and 29 c 7 at 45 minutes of 
reperfusion. Myocardial oxygen consumption was not diffcr- 
ent bctween groups at baseline but was increased in DC’A 
rcperfused hearts versus control hcarts at 45 minutes of 
reperfusion (Fig 5). Basclinc MCO, was 63 rr 10 mligimin 
and 67 rc 10 mL/g/min in control and DCA hearts. 
rcspcctively, and at 45 minutes of rcperfusion was 32 -t 11 
in control versus 48 + 12 in DCA hcarts (P < 0.05). 
Likewisc. %O, extraction was not different betwccn groups 
Tsble 1. Mvocardial Functional Indices: Baseline and 45’ Reperfusion 
Group 
Developed 
PWSSUVZ % Recove~ dP/dl % Recovery l-1dP:dt %Recovery 
N ImmHgl DP (mmliglsec) dP/dl ImmHg/sec) Ik)dPldt 
Control 10 
Baseline 103 - 13 1,550 2 247 1,282 + 200 
45' Reperf 39 t 12 37 t 8 670 + 190 43 - 10 483 - 146 38 i 10 
DCA 6 
Baseline 118 i 14 1,758~ 271 1,290 i 131 
45' Reperf 73 i 11' 62 + 4' 1.175 t 174' 67 i 5' 810 + 120' 63 f 10' 
??f ‘: 0.05. 




Fig 4. Diartdic compliance at baseline and at 45 
minutes of repetfusion. y axis is the linearized slop0 
of EDp/EDV. Valuea are maans + standard deviation. 
??P c 0.05. n, CON; H, DCA. 
at baseline, hut was increascd in DCA hearts versus control 
hearts at 45 minutes of reperfusion (74% & 6% v 
40% r 17%,P < 0.05). 
The change in intramyocardial pH during rcperfusion 
was not different between control hearts and thosc receiv- 
ing DCA as measured by this technique (Fig 6). 
DISCUSSION 
These results indicate that DCA administration during 
reperfusion significantly improves myocardial functional 
and metabolic recovery following cold, cardioplegic global 
ischemia. The mechanism of this enhanced recovery may bc 
dut either to metabolic alterations or inotropic support of 
thc reperfused myocardium. 
Myocardial ischemia and the etfcct of reperfusion have 
been extensivcly studied, often using isolated hcart prepara- 
tions. These preparations are uscful in that metabolic 
processes can bc manipulated in a wide variety of ways and 
the effect of such manipulation on functional recovery 
studied. There are scveral types of global ischemic models 
in thc literaturc: (1) warm, working global ischemia with 
ncither substrate nor oxygen supplied, (2) warm working 
global anoxia with substratc perfusion, (3) cold cardioplegic 
arrest with neithcr substratc nor oxygen supplied. Thc fìrst 
two rcprescnt thc conditions of suddcn death or cardiac 
REFl&lJsm 
arrest (myocyte nccrosis), whereas the latter mimics the 
conditions of thc heart during bypass or the heart harvested 
for transplantation (myocyte stunning). The ability of the 
myocardial ccll to recover functionally following an isch- 
cmic insult is variable, depending on the duration of the 
ischemia and the mctabolic conditions existing prior to, 
during, and aftcr ischemia. Although thc final pathway for 
recovery appears to be rcpletion of high-energy phosphate 
or ATP levcls, it is not yet certain which conditions before 
or after ischcmia enable thc cel] to restore energy levels to 
normal during rcperfusion. Factors that appear to diminish 
the ccll’s ability to regenerate ATP include decreased 
availability of adenosine nucleotides,O-y Ca+ + levels,‘OJ1 and 
the accumulation of glycolytic mctabolites, including lac- 
late, H+. NADH, and oxygen free radicals.“-IJ 
Ender normal metabolic conditions. the metabolism of 
frcc fatty acids providcs nearly 70% of the high-energy 
phosphate bonds required for normal function.14 Following 
a period of hypoperfusion or total global ischemia, the 
myocardial cell is critically dcpendent on glycolysis for 
functional recovery during reperfusion.‘“J During isch- 
emia, as the supply of cellular oxygen diminishes, electron 
flux through the electron transport chain falters and as 
NADH accumulates, oxidative phosphorylation ceases. Tbe 
consequent decreasc in ATP levels directly stimulates 
Table 2. Myocardial Metabolic Indices: gasoline and 45’ Repetfusion 
Group 
CEF % Recoverv MVO, % Recoven/ % Recovery 
N InlL/g) CBF mLigim4n MV02 DPIMVO, OPIMYO, 
Control 10 
Baseline 41 t 9 63 f 10 1.7 * 0.4 
45’ Reperf 38% 12 92 t 23 32 + 11 51 + 19 1.3 f 0.5 76 
DCA 6 
Baseline 38 + 5 67 z 10 1.8 + .4 
45’ Reperf 29 _f 7 75 + 5 48* 12. 72 z 10. 1.6 + 0.4 88 
‘P c: 0.05. 
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Fig 5. Myocardial mstabolic recovery at 45 minutes of reperfusion. 
Abbreviations: CBF, coronary blood flow; ho,, myocardial oxygen 
consumption; DP/MV02, developed pressure per myocardial oxygen 
consumption. Values are means + standard deviation. ??P c 0.05. 
anaerobic glycolysis, increasing pyruvatc production; thc 
NAD+ required for this pathway comes from the formation 
of lactate from pyruvate. In addition, the accumulation of 
reduced NADH inhibits the activity of pyruvate dehydrogc- 
nase (PDH), thc multienzyme complex responsible for 
oxidation of pyruvate to acetyl CoA and thereby its entry 
into the Krebs cycle.‘.lr’ Cellular ischemia thus quickly 
rcsults in dcpletion of ATP stores and accumulation 01 
lactatc and H+ ions. 
The mechanisms of the beneficial effect of DCA that 
have been found may relatc to DCA’s ability to stimulatc 
thc activity of pyruvate dehydrogenasc.1.3,‘Z,‘f1 DCA has 
been shown to increase thc activity of PDH in bram. hcart. 
7.6 
1 T T 1 1 
skclctal mus&. iidiposc tissue. platclet-enrichcd plasma. 
and tihroblasts with maximal stimulation gcncrally occur- 
ring at a conccntration of I mmol: L.: I3y dircctly incrcasing 
the activity of PDH. DCA may overridc thc ncgativc 
fecdback loop of NADH accumulation. incrcasing thc 
amount of pyruvate metabolized to acctyl CoA. thus incrcas- 
ing oxidative phosphorylation during reperfusion. 
DCA’s effect on metabolic and mechanica1 recovery 
following glohal ischcmia has been studied in various 
isolatcd hcart models. In a model of warm. working, glohal 
ischcmia, Kaccy-Burns ct aliJ showcd that rat hcarts 
reperfused with DCA had lower lactatc Icvels, improvcd 
myocardial function. and elevated ATP levels comparcd to 
control hcarts. In anothcr model of warm, working ischemia 
in rat hcarts. McVcigh and LopashucklJ tirst inhibited 
glycolysis by infusion of frce fatty acids (FFA). thcn 
subjcctcd the hearts to 2.5 to 30 minutcs of warm ischcmia. 
Rcpcrfusion was accomplishcd with a PSS containing FFA 
or PSS + FFA + DCA. Functional rccovcry and glucose 
oxidation were cnhanccd with DCA, but ATP Icvcls were 
not different from control hearts. Finally, Mallct st al’- 
studicd guinca pig hcarts subjccted to 25 minutes of global 
low-tlow pcrfusion with concurrent norcpinephrinc infu- 
sion to cxhaust glycogcn stores. Thc hearts wcrc repcrfuscd 
with a variety of solutions, including glucose alons. glucose 
and pyruvatc. glucose and DCA. and pyruvatc and DCA. 
They found that DCA and glucose. whcn addcd to thc PSS 
uscd during rcperfusion, increascd functional recovery. 
incrcascd ATP levcls, and lowcrcd lactate lcvcls. Thcrc are 
no previous rcports of DC’A usc in ;I model of cold. 
cardioplcgic arrest. Howevcr, these rcsults indicatc thut the 
bcneticial effect of DCA is not tcmperaturc-dependcnt. 
Although DCA is known to limit lactic acidosis in hypoxic 
scttings.‘-‘.i and dccrcascd lactate levcls in two isolatcd 
hcart reperfusion models.i~.‘” no dilfercncc was found 
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dia1 pH returned to 7.2 within 2 minutes of reperfusion in 
both control and DCA hcarts, most likely due to rapid 
washout of anaerobic byproducts with a pH-baianced reper- 
fusion solution. Therefore, the improvcd functional recov- 
ery secn with DCA in this model cannot bc simply ascrihcd 
to amelioration of acidosis. 
DCA may also have inotropic propcrtics. When studicd 
in a model of endotoxin-shocked rat hearts without isch- 
emia, DCA enhanced the inotropic effect of both amrinone 
and ouabain and indcpendently increascd glucose oxida- 
tion in these hearts.’ The enhanced oxygen consumption 
noted with DCA administration could bc cithcr cause or 
effect of improved function. An incrcasc in myocardial 
mechanica1 use efficiency was found, ie, the amount of work 
done per milliliter of oxygen consumed, in hcarts rcpcr- 
fuscd with DCA. This interesting effect has been notcd in 
othcr studies of DCA, including one performed in 9 
patients with known coronary artery discase,‘: and in a 
study of hypoxic lactic acidosis in dogs.lx An improvcmcnt 
in both myocardial function and oxygen use during DCA 
administration were noted, but can only bc speculatcd 
whcther the myocardial functional recovery it notcd was 
dut to a direct inotropic effect of DCA, due to enhanccd 
oxidative phosphorylation and ATP replction during rcpcr- 
fusion, or rcsulted from an altered myocardial oxygcn usc. 
In summary, DCA is a promising new agent capable of 
cnhancing myocardial functional recovery and improving 
mechanica1 use efficiency when administered following 
induced global ischcmia. but further study will be rcquired 
to delincate thc exact nature of its bcnctïcial effect. 
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